Xiaotan Jieyu Prescription Alleviates Breast Precancerous Lesions through PI3K/Akt Signaling Pathway.

Jing ZhaoTao PangJian-Peng JiaoBin WangXuan LiuLi-Juan XiuDa-Zhi Sun Xiao-Qiang Yue Chao-Qin Yu

Published in: Evidence-based complementary and alternative medicine : eCAM (2020)

These data indicated that XTJY can significantly alleviate the development of breast precancerous lesions by inhibiting the activation of the PI3K/Akt signaling pathway. XTJY may be a promising drug for the treatment of precancerous lesions in breast cancer.

Keyphrases

signaling pathway
pi k akt
cell cycle arrest
induced apoptosis
epithelial mesenchymal transition
cell proliferation
electronic health record
emergency department
cell death
young adults
artificial intelligence
deep learning
drug induced
data analysis